
Sove IT 6.25mg Tablet ER
Marketer
Ipca Laboratories Ltd
Salt Composition
Zolpidem (6.25mg)
Overview Sove IT 6.25mg Tablet ER
Restoril ER 6.25mg tablets offer short-term relief from insomnia. They shorten sleep onset and reduce nighttime awakenings, promoting sustained sleep. Take Restoril ER 6.25mg on an empty stomach, ideally before bed, at the same time daily for consistent blood levels. Follow your doctor's prescribed dosage and duration; this medication is habit-forming and should not be discontinued abruptly without consulting your physician. Potential side effects include memory impairment, visual disturbances (including double vision), headaches, dizziness, nausea, vomiting, diarrhea, agitation, back pain, fatigue, stomach upset, depression, and hallucinations. Most side effects are temporary; however, report any persistent or concerning effects to your doctor. Drowsiness and dizziness are common; avoid driving or activities requiring alertness until you understand the effects. Alcohol should be avoided. Report any unusual mood changes, worsening depression, hallucinations, or suicidal thoughts immediately. Inform your doctor about all other medications you are taking, pre-existing liver or kidney conditions, and any alcohol or tobacco use before starting Restoril ER. This medication is contraindicated during pregnancy and breastfeeding; consult your doctor if necessary.
Uses of Sove IT 6.25mg Tablet ER
Managing Sleep Difficulties
Major Benefits of Sove IT 6.25mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer Sove IT 6.25mg Extended-Release Tablet on an empty stomach.
Common Side effects of Sove IT 6.25mg Tablet ER:
- Dizziness
- Sleepiness
- Headache
- Nausea
- Stomach pain
- Memory loss
- Vertigo
- Vomiting
- Back pain
- Agitation
- Double vision
- Depression
How to use Sove IT 6.25mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Administer the 6.25mg extended-release Sove IT tablet on an empty stomach.
How Sove IT 6.25mg Tablet ER works:
Sove IT 6.25mg Extended-Release Tablets are classified as non-benzodiazepine sleep aids. This medication exhibits hypnotic, sedative, and anticonvulsant effects, controlling seizures. Its mechanism involves interaction with the GABAA receptor chloride channel complex, a neurotransmitter receptor, thereby reducing neuronal activity in the brain and promoting sleep onset.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Sove IT 6.25mg Extended-Release tablets and alcohol may result in increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Extended-release Sove IT 6.25mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescription. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
Extended-release Sove IT 6.25mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer into breast milk, posing no known risk to the infant.
DrivingUNSAFE
Extended-release Sove IT 6.25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from operating vehicles if these side effects manifest.
KidneySAFE IF PRESCRIBED
Extended-release Sove IT 6.25mg tablets are considered safe for use by individuals with kidney impairment. No dosage modification is necessary for this medication. Nevertheless, disclosure of any kidney condition to your physician is advised.
LiverCAUTION
Exercise caution when administering Sove IT 6.25mg Extended-Release Tablets to individuals with hepatic impairment. Dosage modification of Sove IT 6.25mg Extended-Release Tablets may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiation of Sove IT 6.25mg Extended-Release Tablets should begin with a low dosage; its use is contraindicated in those with severe liver disease.
What if you forget to take Sove IT 6.25mg Tablet ER :
Omit any missed Sove IT 6.25mg Extended-Release Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sove IT 6.25mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Imidazopyridine Compound |
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Action Class | Non-benzodiazepine sleeping pills (Z-drugs) |
